INS and obesity disorder: In adipose tissue, SPMs counter obesity-associated TNF signaling that desensitizes insulin pathways in adipocytes: lipoxins restore IRS-1 phosphorylation and stimulate Akt activation, facilitating GLUT4 vesicular translocation and improving insulin responsiveness [50,51,52].